Rebamipide, Alpha Lipoic Acid, Acetylcysteine

Rebamipide is a synthetic, benzimidazole derivative compound that primarily functions as a gastrointestinal (GI) cytoprotective agent. It works by protecting the lining of the stomach and intestines from damage caused by acid, bile, and other harmful substances. Rebamipide is primarily used for the treatment of chronic gastritis, peptic ulcers, and other GI disorders. It aids in promoting the healing process and reducing inflammation, ultimately improving the overall health and function of the GI tract.
Alpha Lipoic Acid (ALA) is an antioxidant that plays a crucial role in cellular energy production and the neutralization of harmful free radicals. It is a powerful compound that can be found both in the mitochondria (the energy-producing part of the cell) and in the cytoplasm (the fluid within the cell). ALA is known for its ability to protect cells from oxidative stress and is often used to support overall health, particularly in individuals with diabetes, liver disease, and neurodegenerative conditions such as Alzheimer’s disease and Parkinson’s disease.
Acetylcysteine is an amino acid derivative that acts as a precursor to the important antioxidant glutathione. It is widely used for its mucolytic properties, which means it helps to thin and break down mucus, making it easier to cough up and expel from the lungs. Acetylcysteine is commonly prescribed for the treatment of respiratory conditions such as bronchitis, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). Additionally, it can be used to prevent acetaminophen toxicity and liver damage, as it is converted into the active form of glutathione, which helps to detoxify harmful substances in the body.